Xencor, Inc. (XNCR)
33.26
-0.75
(-2.21%)
USD |
NASDAQ |
Nov 20, 16:00
33.28
+0.02
(+0.06%)
After-Hours: 20:00
Xencor Gross Profit Margin (Quarterly) : 98.08% for Sept. 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 98.08% |
| June 30, 2026 | 95.24% |
| March 31, 2026 | 43.16% |
| December 31, 2025 | 90.87% |
| September 30, 2025 | 87.62% |
| June 30, 2025 | 93.92% |
| March 31, 2025 | 91.77% |
| December 31, 2024 | 94.33% |
| September 30, 2024 | 71.48% |
| June 30, 2024 | 82.17% |
| March 31, 2024 | 76.30% |
| December 31, 2023 | 92.78% |
| September 30, 2023 | 94.69% |
| June 30, 2023 | 93.66% |
| March 31, 2023 | 88.16% |
| December 31, 2022 | 90.01% |
| September 30, 2022 | 91.80% |
| June 30, 2022 | 92.63% |
| March 31, 2022 | 97.45% |
| December 31, 2021 | 98.63% |
| September 30, 2021 | 0.00% |
| June 30, 2021 | 0.00% |
| March 31, 2021 | 0.00% |
| December 31, 2020 | 0.00% |
| September 30, 2020 | 0.00% |
| Date | Value |
|---|---|
| June 30, 2020 | 0.00% |
| March 31, 2020 | 0.00% |
| December 31, 2019 | 0.00% |
| September 30, 2019 | 0.00% |
| June 30, 2019 | 94.83% |
| March 31, 2019 | 0.00% |
| December 31, 2018 | 0.00% |
| September 30, 2018 | 0.00% |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 0.00% |
| September 30, 2017 | |
| June 30, 2017 | 0.00% |
| March 31, 2017 | 88.29% |
| December 31, 2016 | 0.00% |
| September 30, 2016 | 0.00% |
| June 30, 2016 | 0.00% |
| March 31, 2016 | 0.00% |
| December 31, 2015 | 0.00% |
| September 30, 2015 | 0.00% |
| June 30, 2015 | 0.00% |
| March 31, 2015 | 0.00% |
| December 31, 2014 | 0.00% |
| September 30, 2014 | 0.00% |
| June 30, 2014 | 0.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Iovance Biotherapeutics, Inc. | 52.64% |
| Ironwood Pharmaceuticals, Inc. | 99.66% |
| UroGen Pharma Ltd. | 91.57% |
| MeiraGTx Holdings Plc | -30.20% |
| IDEAYA Biosciences, Inc. | 89.93% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -20.75% |
| Return on Assets | -14.82% |
| Return on Invested Capital | -15.77% |
| Profit Margin (Quarterly) | 33.84% |
| Operating Margin (Quarterly) | 19.62% |
| Return on Net Operating Assets | -90.54% |